In conclusion, our results demonstrate that the low expression of RICH1 is associated with poor prognosis and CSCs-like properties in breast cancer, and its overexpression potentiates Hippo signaling through competing with Merlin for binding to Amot-p80, which further inhibits stemness and improve the chemosensitivity of breast cancer cells. The gene discussed is NF2; the disease is breast carcinoma.